TRIFIRO', Gianluca
 Distribuzione geografica
Continente #
EU - Europa 9.719
NA - Nord America 8.396
AS - Asia 5.472
SA - Sud America 2.016
AF - Africa 170
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.792
Nazione #
US - Stati Uniti d'America 8.210
RU - Federazione Russa 5.190
SG - Singapore 2.189
BR - Brasile 1.750
CN - Cina 1.519
IE - Irlanda 1.278
SE - Svezia 1.046
HK - Hong Kong 658
IT - Italia 456
VN - Vietnam 426
DE - Germania 350
FR - Francia 286
PL - Polonia 285
UA - Ucraina 222
FI - Finlandia 205
GB - Regno Unito 154
IN - India 154
AR - Argentina 96
CA - Canada 80
BD - Bangladesh 68
TR - Turchia 68
MX - Messico 59
EC - Ecuador 56
NL - Olanda 52
ZA - Sudafrica 49
IQ - Iraq 48
ID - Indonesia 43
PK - Pakistan 42
UZ - Uzbekistan 40
BE - Belgio 37
MA - Marocco 37
JP - Giappone 36
VE - Venezuela 36
RO - Romania 30
AT - Austria 21
PY - Paraguay 21
ES - Italia 19
AE - Emirati Arabi Uniti 18
CO - Colombia 17
KE - Kenya 17
SA - Arabia Saudita 16
TN - Tunisia 16
EG - Egitto 14
LT - Lituania 14
AZ - Azerbaigian 13
CL - Cile 13
MY - Malesia 12
PE - Perù 12
PH - Filippine 12
DZ - Algeria 11
JO - Giordania 11
NP - Nepal 11
KZ - Kazakistan 10
OM - Oman 10
PA - Panama 10
AL - Albania 9
AU - Australia 9
BO - Bolivia 9
CH - Svizzera 8
CR - Costa Rica 8
ET - Etiopia 8
IR - Iran 8
JM - Giamaica 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
IL - Israele 6
LB - Libano 6
NI - Nicaragua 6
BY - Bielorussia 5
QA - Qatar 5
RS - Serbia 5
UY - Uruguay 5
BN - Brunei Darussalam 4
CI - Costa d'Avorio 4
EE - Estonia 4
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
KR - Corea 4
LK - Sri Lanka 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BG - Bulgaria 3
CY - Cipro 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
MD - Moldavia 3
PT - Portogallo 3
SI - Slovenia 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AO - Angola 2
BW - Botswana 2
Totale 25.760
Città #
Moscow 1.564
Ashburn 1.350
Dublin 1.267
Singapore 1.145
Chandler 992
Dallas 895
Hong Kong 657
Beijing 520
Jacksonville 510
Nyköping 487
San Jose 331
Warsaw 272
The Dalles 270
Princeton 241
Los Angeles 203
Lauterbourg 197
Medford 186
Messina 180
Cambridge 179
Dearborn 161
Des Moines 154
Dong Ket 135
Ann Arbor 132
São Paulo 122
New York 119
Ho Chi Minh City 104
Boardman 101
Munich 89
Buffalo 85
Redondo Beach 85
Tianjin 81
Council Bluffs 70
Wilmington 69
Guangzhou 60
Hanoi 60
Shenyang 57
Rio de Janeiro 56
Jinan 51
Bremen 49
Orem 47
Santa Clara 45
Belo Horizonte 44
Frankfurt am Main 41
San Mateo 39
Tashkent 39
Brussels 37
Nanjing 35
Tokyo 35
Hyderabad 33
Rome 33
Chennai 32
Houston 32
Brasília 30
Woodbridge 30
Focsani 29
Seattle 29
Curitiba 28
Chicago 24
Montreal 24
Pune 24
Brooklyn 23
Shanghai 23
Baghdad 22
Haiphong 22
Helsinki 22
Johannesburg 22
Milan 22
Campinas 21
Denver 20
Guayaquil 20
Nuremberg 20
Phoenix 20
Shenzhen 20
Falls Church 19
Haikou 19
Hebei 19
Jakarta 19
Salvador 19
London 18
Porto Alegre 18
Catania 17
Turku 17
Amsterdam 16
Atlanta 16
Dhaka 16
Hangzhou 16
Ningbo 16
Taizhou 16
Ankara 15
Lanzhou 15
Nairobi 15
Ottawa 15
Stockholm 15
Fortaleza 14
Guarulhos 14
Juiz de Fora 14
Lancaster 14
Poplar 14
Quito 14
Istanbul 13
Totale 14.706
Nome #
1. Real World Evidence vs. Real World Data: definizioni e razionale 260
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 231
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 224
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 207
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 189
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 187
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 185
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 184
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 184
Analgesic drug use in elderly persons: A population-based study in Southern Italy 183
Global epidemiology of acromegaly: A systematic review and meta-analysis 179
Drug safety information through the internet: the experience of an Italian website. 178
Absorbable phosphate in medication 173
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari 168
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 168
Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis 167
Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy 167
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 166
About reimbursement criteria revision: effects on lipid lowering drug use in general practice of Southern Italy 166
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 166
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 165
Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice 164
Antipsychotic use in dementia patients in a general practice setting: A Dutch population-based study 164
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study 163
Adverse drug events in emergency department population: a prospective Italian study 163
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 163
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations 162
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 161
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy 161
Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries 159
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy 159
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 158
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 157
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study 157
CEREBELLAR STROKE IN ELDERLY PATIENT WITH BASILAR ARTERY AGENESIA: A CASE REPORT. 155
Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy 155
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 154
Burden of cardiovascular disease in elderly with Parkinson's disease who start a dopamine agonist agent 154
Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System 154
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 151
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 148
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 148
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 146
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 146
Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database 145
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 145
Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia 144
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 143
Prescribing pattern of drugs in the treatment of osteoarthritis before and after rofecoxib withdrawal in general practice of Southern Italy 141
'Use of Antipsychotics in Children and Adolescents: A Picture From the ARITMO Population-Based European Cohort Study' 141
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 140
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 140
Expert opinion of nephrologists about the effectiveness of low-protein diet in different stages of chronic kidney disease (CKD) 139
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 138
Diagnostic Yield of 2 Strategies for Adult Celiac Disease Identification in Primary Care 138
Adherence to gastroprotection during cyclooxygenase-2 inhibitor use and the risk of upper gastrointestinal events: A population-based study. 137
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 137
USE AND TOLERABILITY OF NEWER ANTIPSYCHOTICS AND ANTIDEPRESSANTS: A CHART REVIEW IN A PAEDIATRIC SETTING. 136
Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses 136
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 133
Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions. 133
Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision 132
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project 131
Profilo di tollerabilità degli antipsicotici atipici e degli inibitori selettivi della ricaptazione della serotonina in età evolutiva. 129
A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection using Electronic Healthcare Records (EHR) Databases 129
Additional risk minimisation measures in the EU - are they eligible for assessment? 129
A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project. 128
Ckd general and clinical epidemiology 2. 128
Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: A population-based cohort study 128
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in southern Italy 126
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 126
Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis 125
Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. 125
Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal. 125
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study 125
Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation. 125
Tolerability of antipsychotics in children and adolescents: a prospective study. 122
From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources 122
Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? 122
Point-of-Care test screening versus Case finding for paediatric coeliac disease: A pragmatic study in primary care 121
Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease. 121
Interaction risk with proton pump inhibitors in general practice: Significant disagreement between different drug-related information sources 121
Lipid-lowering drug use in general practice of Southern Italy: Effects of reimbursement criteria revision 120
Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources 120
The economic burden of preventable adverse drug reactions: a systematic review of observational studies 119
Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in The Netherlands 118
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 118
All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: a multi-center retrospective cohort study in Italy 118
All-cause mortality associated with atypical and typical antipsychotics in demented outpatients 115
Academic output from EU-funded health research projects 115
Pharmacokinetics of new oral anticoagulants: implications for use in routine care 115
“Prescribing pattern of antipsychotic drugs in Italy: a population based study in the the years 2000-2005” 113
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study 113
The European List of Key Medicines for Medical Education: A Modified Delphi Study 111
Medication is an additional source of phosphate intake in chronic kidney disease patients 111
Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: results from a prospective cohort study in the Sicilian general practice setting 111
Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during 1999-2002 years 110
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? 110
Data Extraction And Management In Networks Of Observational Health Care Databases For Scientific Research: A Comparison Among EU-ADR, OMOP, Mini-Sentinel And MATRICE Strategies 110
Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas 110
Totale 14.562
Categoria #
all - tutte 96.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 0 0 0 0 0 0 161
2021/20221.457 7 97 16 41 39 14 72 70 36 406 157 502
2022/20233.591 289 263 160 285 295 346 43 184 1.573 13 109 31
2023/2024865 76 152 52 83 77 172 26 53 3 49 10 112
2024/20254.318 61 58 78 240 164 113 101 999 1.184 262 316 742
2025/202612.466 562 827 1.016 844 1.082 2.720 1.369 1.648 1.504 513 218 163
Totale 26.364